Company / SG&A per Share
Cogent Biosciences, Inc. SG&A per Share History
FY2017-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A per Share
$0.49
FY2025
5-year range
$0.42 / $0.51
FY2021-FY2025
Trend
+18.4%
vs FY2024
Sector context
#164 of 208
Health Care
What the data says
Cogent Biosciences, Inc.'s sg&a per share of $0.49 is lower than 79% of companies in the Health Care sector (FY2025). SG&A per Share returned to growth in FY2025 after 4 years of decline, reaching $0.49.
Based on SEC 10-K filings.
0.49 in FY2025 with a 5-year CAGR of -20.7%.
Increased from $0.43 to $0.49 over the past 2 years.
Health Care sector context is included.
SG&A per Share over time
Growth rates
- 3-Year CAGR
- +3.4%
- 5-Year CAGR
- -20.7%
- 10-Year CAGR
- -
Sector benchmark
Top 21% in Health CareTop 21% of 208This company $0.49 Sector average $29.78
▼
-98.3% below sector average
Key checks
Key Insights
- In FY2025, sg&a per share increased 18.4% year-over-year.
- Ranks #164 out of 208 companies in the Health Care sector.
- Peak sg&a per share was recorded in FY2020.
- Lowest sg&a per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score 0.43 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | SG&A per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.49 | +18.4% |
| FY2024 | $0.42 | -3.4% |
| FY2023 | $0.43 | -3.3% |
| FY2022 | $0.45 | -12.0% |
| FY2021 | $0.51 | -67.7% |
| FY2020 | $1.57 | +9.2% |
| FY2019 | $1.44 | +380.7% |
| FY2018 | $0.30 | -34.8% |
| FY2017 | $0.46 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026